US2021393511A1PendingUtilityA1

Otic gel formulations for treating otitis externa

65
Assignee: OTONOMY INCPriority: Sep 16, 2016Filed: Jun 17, 2021Published: Dec 23, 2021
Est. expirySep 16, 2036(~10.2 yrs left)· nominal 20-yr term from priority
Inventors:Carl Lebel
A61K 9/0046A61K 31/496A61K 31/133A61K 9/06A61K 47/10A61K 9/0004Y02A50/30
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed herein are methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . (canceled) 
     
     
         4 . (canceled) 
     
     
         5 . (canceled) 
     
     
         6 . (canceled) 
     
     
         7 . (canceled) 
     
     
         8 . (canceled) 
     
     
         9 . (canceled) 
     
     
         10 . (canceled) 
     
     
         11 . (canceled) 
     
     
         12 . (canceled) 
     
     
         13 . (canceled) 
     
     
         14 . (canceled) 
     
     
         15 . (canceled) 
     
     
         16 . (canceled) 
     
     
         17 . (canceled) 
     
     
         18 . (canceled) 
     
     
         19 . A kit comprising: a syringe and an aqueous thermoreversible gel composition, wherein the composition comprises about 6.0% by weight of micronized ciprofloxacin and 15-17% by weight of poloxamer 407, and wherein the kit further comprises an instruction to prepare and inject 0.2 mL of the thermoreversible gel composition to provide a single dose of about 12 mg of micronized ciprofloxacin. 
     
     
         20 . The kit of  claim 19 , wherein the instruction is provided on a package insert. 
     
     
         21 . The kit of  claim 19 , wherein the composition is free of butylated hydroxytoluene (BHT). 
     
     
         22 . The kit of  claim 19 , wherein the composition is preservative-free. 
     
     
         23 . The kit of  claim 19 , wherein the composition further comprises a buffering agent. 
     
     
         24 . The kit of  claim 23 , wherein the buffering agent comprises tromethamine. 
     
     
         25 . The kit of  claim 19 , wherein the composition further comprises a pH adjusting agent. 
     
     
         26 . The kit of  claim 25 , wherein the pH adjusting agent comprises hydrochloric acid. 
     
     
         27 . The kit of  claim 19 , wherein the composition has a pH of about 7.0 to about 8.0. 
     
     
         28 . The method of  claim 19 , wherein the composition further comprises an osmolarity modifier. 
     
     
         29 . The method of  claim 19 , wherein the osmolarity modifier comprises sodium chloride. 
     
     
         30 . The method of  claim 19 , wherein the composition has an osmolarity of from about 250 mOsm/kg to about 300 mOsm/kg. 
     
     
         31 . The method of  claim 19 , wherein the composition has a gelation temperature of from about 20° C. to about 30° C.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.